bioMerieux SA- Strategy and SWOT Report

bioMerieux SA - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.

Features:

• Detailed information on bioMerieux SA required for business and competitor intelligence needs
• A study of the major internal and external factors affecting bioMerieux SA in the form of a SWOT analysis
• An in-depth view of the business model of bioMerieux SA including a breakdown and examination of key business segments
• Intelligence on bioMerieux SA’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about bioMerieux SA, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

bioMerieux is a part of the Institut Merieux group. The company is engaged in providing in-vitro diagnostics for medical and industrial applications. It operates in EMEA (Europe, Middle East and Africa), North America, Asia-Pacific and Latin America. The company is headquartered in Marcy l'Etoile, France and employed 6,306 people as of December 2010. The company recorded revenues of E1,357 million (approximately $1,800.3 million) during the financial year ended December 2010 (FY2010), an increase of 10.9% over FY2009. The operating profit of the company was E244 million (approximately $323.7 million) during FY2010, an increase of 12.8% over FY2009. The net profit was E158.7 million (approximately $210.5 million) in FY2010, an increase of 7.4% over FY2009.

Reasons to Purchase:

• Gain understanding of bioMerieux SA and the factors that influence its strategies
• Track strategic initiatives of the company and latest corporate news and actions
• Assess bioMerieux SA as a prospective partner, vendor or supplier
• Support sales activities by understanding your customers' businesses better
• Stay up to date on bioMerieux SA’s business structure, strategy and prospects